The drug ABSEAMED contains one active pharmaceutical ingredient (API):
Epoetin alfa is a glycoprotein hormone produced primarily by the kidney in response to hypoxia and is the key regulator of red blood cell (RBC) production. Epoetin alfa is involved in all phases of erythroid development, and has its principal effect at the level of erythroid precursors.
Below package inserts are available for further reading:
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
This brand name is authorized in the following countries: Austria Cyprus Germany Estonia Ireland Lithuania Poland
This drug has been assigned below unique identifiers within the countries it is being marketed: